Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Institute of Hearing and Speech-Language Science, Sun Yat-sen University, Guangzhou, China.
Cell Death Dis. 2017 Oct 5;8(10):e3079. doi: 10.1038/cddis.2017.462.
Age-related hearing loss is a major unresolved public health problem. We have previously elucidated that the activation of cochlear miR-34a is correlated with age-related hearing loss in C57BL/6 mice. A growing body of evidence points that aberrant autophagy promotes cell death during the development of multiple age-related diseases. The aim of this study was to investigate the role of miR-34a-involved disorder of autophagy in the pathogenesis of age-related hearing loss. Our results showed that miR-34a expression was markedly upregulated in the aging cochlea accompanied with impairment of autophagic flux. In the inner ear HEI-OC1 cell line, miR-34a overexpression resulted in an accumulation of phagophores and impaired autophagosome-lysosome fusion, and led to cell death subsequently. Notably, autophagy-related protein 9A (ATG9A), an autophagy protein, was significantly decreased after miR-34a overexpression. Knockdown of ATG9A inhibited autophagy flux, which is similar to the effects of miR-34a overexpression. Moreover, ursodeoxycholic acid significantly rescued miR-34a-induced HEI-OC1 cell death by restoring autophagy activity. Collectively, these findings increase our understanding of the biological effects of miR-34a in the development of age-related hearing loss and highlight miR-34a as a promising therapeutic target for its treatment.
年龄相关性听力损失是一个尚未解决的重大公共卫生问题。我们之前已经阐明,耳蜗 miR-34a 的激活与 C57BL/6 小鼠的年龄相关性听力损失有关。越来越多的证据表明,异常的自噬会促进多种与年龄相关的疾病的发展过程中的细胞死亡。本研究旨在探讨 miR-34a 参与的自噬异常在年龄相关性听力损失发病机制中的作用。我们的结果表明,miR-34a 在衰老耳蜗中的表达显著上调,同时伴有自噬流的损伤。在内耳 HEI-OC1 细胞系中,miR-34a 的过表达导致吞噬体的积累和自噬体-溶酶体融合受损,随后导致细胞死亡。值得注意的是,自噬相关蛋白 9A(ATG9A),一种自噬蛋白,在 miR-34a 过表达后显著减少。ATG9A 的敲低抑制了自噬流,这与 miR-34a 过表达的效果相似。此外,熊去氧胆酸通过恢复自噬活性显著挽救了 miR-34a 诱导的 HEI-OC1 细胞死亡。总之,这些发现增加了我们对 miR-34a 在年龄相关性听力损失发展过程中的生物学作用的理解,并强调 miR-34a 是治疗该疾病的有前途的治疗靶点。